๐Ÿ”ฌDeep Research

ALEC โ€” Alector Inc ยท catalysts, narrative & risks

ยท23 sourcesALEC forecast โ†’

Snapshot (as of Oct 2, 2026)

Alector Inc. (NASDAQ: ALEC) closed at ~$1.81, down 2.69% that session, with a market cap of ~$202M and a 52-week range of $1.09โ€“$3.40 [21], [22], [23]. This matches the on-file data (healthcare/biotechnology, ~$206.57M market cap) [20], [23]. The company is a clinical-stage biotech building its strategy around the Alector Brain Carrier (ABC) blood-brain barrier platform [24].

Recent catalysts (last ~1โ€“3 months)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’